⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22479799 | 0.73 | — | — | |
| SCHEMBL22927260 | 0.72 | — | — | |
| SCHEMBL1132764 | 0.69 | — | — | |
| SCHEMBL9383143 | 0.69 | — | — | |
| SCHEMBL21610507 | 0.60 | — | — | |
| SCHEMBL12948114 | 0.58 | FBP1 (0.31) | — | |
| SCHEMBL860261 | 0.57 | P2RX7 (0.35) | — | |
| SCHEMBL16019508 | 0.57 | PTGS1 (0.32) | — | |
| SCHEMBL9004531 | 0.56 | — | — | |
| SCHEMBL8016425 | 0.55 | MEN1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10014121-B2 | Solar cells with enhanced solar capture | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-07-03 | — | — | US | disclosed |
| US-20170221641-A1 | SOLAR CELLS WITH ENHANCED SOLAR CAPTURE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2017-08-03 | — | — | US | disclosed |
| US-20150238506-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2015-08-27 | — | — | US | disclosed |
| WO-2014113485-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | INTERMUNE, INC. (US) | 2014-07-24 | — | — | WO | disclosed |
| US-20120157403-A1 | BICYCLIC AND TRICYCLIC DERIVATIVES AS THROMBIN RECEPTOR ANTAGONISTS | CHACKALAMANNIL SAMUEL (US) | 2012-06-21 | — | — | US | disclosed |
| US-20110124676-A1 | BIARYL SUBSTITUTED AZABICYCLIC ALKANE DERIVATIVES | ABBOTT LABORATORIES (US) | 2011-05-26 | — | — | US | disclosed |
| US-7446199-B2 | Compositions useful as inhibitors of protein kinases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-11-04 | — | — | US | disclosed |
| US-20080090830-A1 | Bicyclic And Tricyclic Derivatives As Thrombin Receptor Antagonists | SCHERING CORPORATION | 2008-04-17 | — | — | US | disclosed |
| US-7169800-B2 | Imidazole compositions useful as inhibitors of protein kinases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-01-30 | — | — | US | disclosed |